Evidence map›Paper›PMID 30519056›Full record

ArticleInfection and drug resistance2018

Extensively drug-resistant

Delia Muntean, Monica Licker, Florin Horhat, Victor Dumitrașcu, Dorel Săndesc, Ovidiu Bedreag, Dorina Dugăeșescu, Dan A Coșniță, Anca Krasta, Luminița Bădițoiu

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Draft genomes of multidrug-resistantMicrobiology resource announcements · 2025
    Article
  2. Multidrug-ResistantTropical medicine and infectious disease · 2025
    Article
  3. Article
  4. Association ofMedicina (Kaunas, Lithuania) · 2022
    Observational
  5. Article
  6. Article
  7. Distribution of NDM1 Carbapenemase-ProducingInfection and drug resistance · 2020
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Delia MunteanVictor Babeș University of Medicine and Pharmacy, Timisoara, Romania, licker.monica@umft.ro.
Monica LickerVictor Babeș University of Medicine and Pharmacy, Timisoara, Romania, licker.monica@umft.ro.
Florin HorhatVictor Babeș University of Medicine and Pharmacy, Timisoara, Romania, licker.monica@umft.ro.
Victor DumitrașcuVictor Babeș University of Medicine and Pharmacy, Timisoara, Romania, licker.monica@umft.ro.
Dorel SăndescVictor Babeș University of Medicine and Pharmacy, Timisoara, Romania, licker.monica@umft.ro.
Ovidiu BedreagVictor Babeș University of Medicine and Pharmacy, Timisoara, Romania, licker.monica@umft.ro.
Dorina DugăeșescuVictor Babeș University of Medicine and Pharmacy, Timisoara, Romania, licker.monica@umft.ro.
Dan A CoșnițăVictor Babeș University of Medicine and Pharmacy, Timisoara, Romania, licker.monica@umft.ro.
Anca KrastaPius Brînzeu Emergency Clinical County Hospital, Timisoara, Romania, licker.monica@umft.ro.
Luminița BădițoiuVictor Babeș University of Medicine and Pharmacy, Timisoara, Romania, licker.monica@umft.ro.
Spitalul Clinic Judeţean de Urgenţă "Pius Brînzeu" Timişoara · ROVictor Babeș University of Medicine and Pharmacy Timișoara · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to identify risk factors for extensively drug-resistant (XDR) MATERIALS AND

methodsThis retrospective case-controlled study was conducted between January 2016 and December 2016 in the ICU of the "Pius Brînzeu" County Emergency Clinical Hospital of Timi oara. Data were collected, in strict confidentiality, from the electronic database of the Microbiology Laboratory and the hospital's electronic medical records. Risk factors were ș investigated by logistic regression. Independent variables with

findingsThe incidence density of coinfection with XDR AB and XDR

conclusionThis association of XDR AB and XDR

Indexed as

extensive drug resistanceICUinfectionsrisk factors

Identifiers

PMID30519056
PMCPMC6233948
OpenAlexW2900329044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.